If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDMTR.L Regulatory News (DMTR)

  • There is currently no data for DMTR

Technical Advisory Board Enhanced

9 Jan 2013 07:00

RNS Number : 1103V
Oxford Advanced Surfaces Group PLC
09 January 2013
 



OXFORD ADVANCED SURFACES GROUP PLC

(AIM: OXA)

 

Technical Advisory Board Enhanced

 

Oxford Advanced Surfaces Group ("OAS") the AIM listed technology developer targeting a number of global markets including consumer and industrial displays, solar panels, eyewear and the electronics and adhesion markets, has today announced a key addition to its Technical Advisory Board ("TAB").

 

From 1 January 2013, Professor Steven Abbott joined Professor Mark Moloney on the OAS TAB. Steven brings with him a wealth of industrial, scientific and commercial knowledge from both research posts and a long commercial career at ICI and MacDermid Autotype, covering all areas of the OAS target markets. He is a Fellow of the Royal Society of Chemistry and an independent consultant to global tier 1 industrial partners.

 

Adrian Meldrum, CEO said:

 

 "We are delighted to welcome Steven to the Advisory Board. He has many years of invaluable experience in the key industries and applications in which we operate and will add significant value to our technical and commercial discussions with prospective users of our technology."

 

Prof Steven Abbott commented:

 

 "I am very excited by the opportunity to work with OAS. Its technology offers a range of innovative solutions to significant problems in the world of manufacturing.."

 

 

Prof Steven Abbott received his Oxford Chemistry D Phil for work carried out at Harvard. His post-doctoral was in the Nobel Prizewinning lab of Jean-Marie Lehn at Strasbourg. He is Visiting Professor at the School of Engineering at the University of Leeds. He has worked many years in the high-tech coating industry and along the way developed a passion for computer models that could give real-world insight to complex scientific issues such as precision coating or polymer/nanoparticle solubilities. He is an independent consultant at Steven Abbott TCNF Ltd where he continues to develop software apps on solubility, surfactancy, adhesion, diffusion and advises internationally on topics as diverse as cosmetic/pharma skin delivery, organic photovoltaics, packaging films and "green" surfactant design.

 

09 January 2013

Enquiries:

 

Oxford Advances Surfaces Group Plc www.oxfordsurfaces.com

Adrian Meldrum, Chief Executive Officer

Philip Spinks, Chief Financial Officer T: 01865 854 807

 

W H Ireland Limited www.wh-ireland.co.uk

John Wakefield / Marc Davies T: 0117 945 3471

 

Lothbury FS Ltd www.lothburyfs.com

Gary Middleton / Michael Padley T: 0203 440 7620

 

 

Editors' Note

 

Oxford Advanced Surfaces Group plc (OAS) is a research-based company that develops and licenses intellectual property and products in the areas of highly reactive chemistry and anti-reflective coatings. The Company's research scientists develop innovative solutions in advanced materials and nano-technology for partners to exploit. The Company's solutions apply to real-world, practical processing and innovation challenges as novel polymer and organic materials are introduced to improve cost, weight, space and performance in new products. Initial applications include advanced adhesion, anti-reflective coatings and particle delivery in markets including conventional and plastic electronics, optics, displays, batteries and solar.

www.oxfordsurfaces.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRANKFDKOBKDDDK
Date   Source Headline
14th Jun 20127:00 amRNSBusiness Development Agreement
29th May 20124:03 pmRNSAGM Statement
25th Apr 20127:00 amRNSPreliminary Results - Commercialisation Underway
24th Feb 20127:00 amRNSAnti-Reflective Technology Development
26th Jan 20122:55 pmRNSHolding(s) in Company
3rd Jan 201212:16 pmRNSHolding(s) in Company
17th Oct 20117:00 amRNSAppointment of Chairman
30th Sep 20117:00 amRNSInterim Results
9th Aug 201110:30 amRNSIndustry leading Anti-Reflective Coating
16th Jun 20119:53 amRNSAnnual Financial Report
21st Apr 20117:00 amRNSJapan Agent Appointed
30th Mar 20117:05 amRNSDirectorate Change
30th Mar 20117:00 amRNSAnnual Financial Report
25th Feb 20117:00 amRNSDirectorate Change
27th Jan 201112:44 pmRNSHolding(s) in Company
24th Jan 20111:18 pmRNSHolding(s) in Company
2nd Dec 20107:00 amRNSTrading Update
30th Nov 20107:00 amRNSOAS delivers key process
29th Sep 20107:00 amRNSInterim results
27th Sep 20101:52 pmRNSHolding(s) in Company
14th Jul 201011:23 amRNSHolding(s) in Company
24th Jun 201011:19 amRNSHolding(s) in Company
16th Jun 20104:31 pmRNSHolding(s) in Company
4th Jun 20103:36 pmRNSHolding(s) in Company
2nd Jun 201010:06 amRNSHolding(s) in Company
28th May 20103:14 pmRNSHolding(s) in Company
25th May 20102:26 pmRNSResult of AGM
7th May 201012:49 pmRNSChange of Adviser
28th Apr 20107:00 amRNSFinal Results
16th Feb 20102:55 pmRNSHolding(s) in Company
12th Feb 201012:59 pmRNSHolding(s) in Company
12th Feb 20107:00 amRNSNotification of Interest
9th Feb 20108:58 amRNSDirectorate Change
4th Jan 20107:00 amRNSDirectorate Change
2nd Dec 200910:13 amRNSAward of Options
25th Sep 20097:00 amRNSDirectorate Change and Interim Results
29th May 20093:37 pmRNSAward of Share Options
22nd May 20099:45 amRNSAGM Statement
27th Apr 20097:00 amRNSPreliminary Results
16th Apr 20094:32 pmRNSNotice of AGM
7th Jan 200911:30 amRNSResignation of Director
18th Dec 200810:59 amRNSAward of Share Options
19th Nov 20087:00 amRNSDirectorate Change
11th Nov 20082:48 pmRNSChange of Auditor
30th Oct 20087:00 amRNSHolding(s) in Company
16th Oct 20087:00 amRNSBusiness Update & new Development Agreement signed
15th Oct 20084:34 pmRNSHolding(s) in Company
29th Sep 20087:00 amRNSInterim Results
9th Sep 20081:51 pmRNSHolding(s) in Company
1st Aug 20087:00 amRNSFundraising and Appointment o

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.